Johnson & Johnson (J&J) has announced that its single-dose vaccine, being used in a clinical trial for health workers, has received approval for use in SA.

SA Health Products Regulatory Authority (Sahpra) CEO Boitumelo Semete-Makokotlela said, “The registration signals a significant step in the fight against the Covid-19 pandemic.”..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now